Skip to content
Screener

Enovis ENOV Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Stryker logo
StrykerSYK
$0.100.0%
ESAB logo
ESABESAB
$00.0%
OrthoPediatrics logo
OrthoPediatricsKIDS
$00.0%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$00.0%
CONMED logo
CONMEDCNMD
VAT
InnovateVATE

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemJuly 3, 2026December 31, 2025
Other liabilities368,630424,568
Total liabilities2,286,9612,342,835
Equity:
Common stock, $0.001 par value; 133,333,333 shares authorized; 57,665,074 and 57,194,781 shares issued and outstanding as of July 3, 2026 and December 31, 2025, respectively5857
Additional paid-in capital3,065,6673,048,414
Accumulated deficit(1,477,417)(1,467,463)
Accumulated other comprehensive loss(111,241)(91,363)
Total Enovis Corporation equity1,477,0671,489,645

Item 1. Financial Statements

FAQ

What is Enovis's common stock, par value (in dollars per share)?
Enovis (ENOV) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
How has Enovis's common stock, par value (in dollars per share) changed year-over-year?
Enovis's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Enovis's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Enovis's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Enovis's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude